FDA
-
-
-
-
-
-
-
Candel Therapeutics to Present at Upcoming Investor Conferences
-
-
-
-
-
-
-
Candel reports extended survival in lung cancer trial
-
-
-
-
-
-
-
Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston
-
-
-
-
-
-
-
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development Summit
-
-
-
-
-
-
-
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London
-
-
-
-
-
-
-
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational Medicine
-
-
-
-
-
-
-
Candel Therapeutics adds CAR-T pioneer Carl June to advisory board
-
322,173 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

